Lehrstuhl für Innere Medizin III

MICRORNA-125B AS A POTENTIAL FIBROTIC AND APOPTOTIC REGULATOR IN SYSTEMIC SCLEROSIS (2017) Kozlova A, Pachera E, Renoux F, Rudnik M, Maurer B, Juengel A, Distler J, et al. Conference contribution METABOLISM AND OSTEOARTHRITIS ARE LINKED BY ADIPOKINES (2017) Huelser ML, Schreiyack C, Luo Y, Bozec A, Schett G, Neumann E, Mueller-Ladner U Conference contribution QUANTITATIVE ASSESSMENT AND ANALYSIS OF HAND MUSCLE VOLUME (2017) Friedberger A, Figueiredo C, Museyko O, Grimm A, D'Oliveira I, Bäuerle T, Rech J, et al. Conference contribution Important Role of CD11c+Dendtritic Cells in Inflammatory Arthritis (2017) Puchner A, Saferding V, Bonelli M, Leiss H, Krönke G, Pfeifle R, Smolen JS, et al. Conference contribution FRA2 OVEREXPRESSION LEADS TO SYSTEMIC AUTOIMMUNITY BY DECREASING IL-2 RESPONSIVENESS AND THYMIC TREG DEVELOPMENT (2017) Renoux F, Stellato M, Impellizzieri D, Vogetseder A, Huang R, Subramaniam A, Dees C, et al. Conference contribution Increased Plasma Levels of Hsp90 Are Associated with More Severe Organ Involvement in Patients with Systemic Sclerosis (2017) Storkanova H, Oreska S, Spiritovic M, Pavelka K, Vencovsky J, Distler J, Senolt L, et al. Conference contribution Fra-2 Overexpression Leads to Systemic Autoimmunity By Affecting IL2 Dependent Treg Homeostasis (2017) Renoux F, Stellato M, Impellizzieri D, Vogetseder A, Blyszczuk P, Huang R, Subramaniam A, et al. Conference contribution INDUCTION OF SUSTAINED REMISSION IN EARLY INFLAMMATORY ARTHRITIS WITH THE COMBINATION OF INFLIXIMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR PLACEBO: THE DINORA TRIAL (2017) Stamm TA, Machold K, Aletaha D, Alasti F, Lipsky P, Pisetsky D, Landewe R, et al. Conference contribution ESTROGEN INFLUENCES THE SIALYLATION PROFILE AND INFLAMMATORY PROPERTIES OF ANTIBODIES - A POTENTIAL EXPLANATION FOR THE SEX DIFFERENCES AND INCREASED RISK FOR RA IN POSTMENOPAUSAL WOMEN (2017) Engdahl C, Raufer J, Harre U, Bondt A, Pfeifle R, Krönke G, Scherer HU, et al. Conference contribution EPIGENETIC REGULATION OF FRA2 BY JMJD3 REGULATES FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS (2017) Bergmann C, Brandt A, Dees C, Wohlfahrt T, Zhang Y, Chen CW, Mallano T, et al. Conference contribution